La compañía de tecnología deportiva Orreco y Scarlet Health se asocian para brindar a los atletas una nueva solución para optimizar su rendimiento

Los Angeles CA – (Sep 1, 2021) Specialist sports performance and biomarker company Orreco have joined forces with Scarlet Health, an on-demand diagnostic service by BioReference Laboratories Inc., an OPKO Health company (NASDAQ:OPK), providing a superior, fully integrated digital solution that addresses modern testing needs, to provide a new solution for pre-season athlete physicals and in-season testing for professional and collegiate athletes.

Scarlet, combined with Orreco’s AI/ML performance algorithms, provides sport specific interpretation of data while cross referencing it with GPS, heart rate and game statistics, in line with each sports collective Bargaining Agreement. 

Profiles can include full bio-analytics, fatigue profiles, nutrition analysis and women’s specific panels, all of which can be accessed via Orreco’ @thlete app. Using Scarlet, athletes can have their specimens collected for profile clinical testing in a team environment or at home, if opting to analyse their own biomarkers with their personal physician and performance staff.

This initiative means athletes in training in every state in the U.S. will be able to access the service. The disrupted schedules and seasons have placed higher than ever demands on players. Machine learning algorithms that take into account game schedules, training data, travel across time-zones, data from wearables and nutrition plans combined with blood test panels can help give truly personalised suggestions and help world class athletes get even better.

Scarlet meets patients where they are – whether they are a world-class athlete optimizing their performance, or a busy parent managing their family’s health – and offers ease of use and convenient access to diagnostics,” said Richard Schwabacher, Chief Digital Officer at BioReference.

adding “Under this new collaboration, Scarlet’s digital seamless integration and our experience providing testing to the majority of professional U.S. sports leagues in combination with Orreco’s best-in-class digital solutions provides elite and high performing athletes access to insightful and valuable diagnostic information that can help advance their performance in new and innovative ways.”

Dr. Brian Moore, CEO, Orreco“Everything we do at Orreco is to help athletes optimize their performance, accelerate their recovery from training and matches and to help prolong their playing careers. Working together with BioReference and Scarlet will enable us to do this at scale and help meet athletes where they are to understand their bodies and personalize their training and nutrition.”

About Orreco: Established in 2010, Orreco has offices in Los Angeles, London and Galway, Ireland. Orreco scientists analyse athlete data and deliver evidence-based, personalized strategies to improve recovery rates, optimize training response and protect against excessive fatigue and under-recovery. By keeping athletes in their peak performance zone, Orreco aims to reduce injury and illness risk for elite athletes and extend playing careers. Orreco scientists have been analysing athlete data for over 20 years in 16 different sports for over 2000 elite athletes. Orreco integrates sports science, data science and systems development and operates as a team within the team. Clients include teams and franchises in the NBA/NFL/EPL/WSL/WNBA/NHL and individual athletes in Olympic sports including 54 medalists, F1 drivers and PGA Tour players. Consulta www.orreco.com

About Scarlet Health: Scarlet is an on-demand diagnostic service providing a superior, fully integrated digital solution that addresses modern testing needs for healthcare providers and patients. Scarlet, gracias al respaldo de la presencia e infraestructura nacional de BioReference, que cuenta con laboratorios y profesionales en todo el país, ofrece una alternativa móvil, innovadora y flexible a los centros de servicio para pacientes tradicionales u otros centros de extracción cuando se necesitan servicios de flebotomía y demás servicios de recolección de muestras. BioReference works with our trusted partners to create customized, fully integrated solutions that plug in seamlessly with existing medical systems. https://www.scarlethealth.com/

About BioReference Laboratories, Inc.: BioReference Laboratories, Inc. es uno de los laboratorios especializados de servicio completo más grandes de los Estados Unidos, que permite a los proveedores de atención médica y a los pacientes tomar decisiones de salud con confianza. BioReference ofrece soluciones de prueba integrales y una experiencia sin igual basada en un legado de 40 años de ciencia comprobada, con énfasis en genética, oncología, urología y salud de la mujer. La compañía trabaja en red con los planes de salud más grandes de los Estados Unidos, atiende a alrededor de 19 millones de pacientes al año, dirige una red de 11 laboratorios y cuenta con el respaldo de un personal médico de más de 300 médicos, osteópatas, doctorados, asesores genéticos y demás personal clínico y científico profesional. BioReference tiene una presencia nacional y experiencia en un nicho de mercado, y ofrece soluciones confiables e innovadoras que satisfacen las necesidades de empleadores, organismos gubernamentales, sistemas educativos, hospitales y sistemas de salud, instituciones penitenciarias, ligas deportivas, industrias de viajes y ocio, y mercados minoristas. BioReference ofrece soluciones personalizadas líderes en la industria para la COVID-19, que incluyen pruebas en el lugar de atención y programas de análisis de detección a gran escala. https://www.bioreference.com/

Advertencia respecto de declaraciones con perspectivas de futuro 
This press release contains “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning, particularly statements regarding BioReference’s Scarlet Health mobile service, the availability of and demand for the service, whether the service and the integrated platform will function or perform as designed, the role and value of the service to patients and healthcare providers and whether the demand for at home health care will continue or increase as anticipated, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Muchos factores podrían hacer que nuestras actividades o resultados reales difieran sustancialmente de las actividades y resultados anticipados en las declaraciones con perspectivas de futuro. Estos factores incluyen aquellos descritos en los informes anuales de OPKO Health, Inc. los informes anuales del formulario 10-K de OPKO Health, Inc. presentados y a presentarse ante la Comisión de Bolsa y Valores y en otras presentaciones nuestras ante la Comisión de Bolsa y Valores. Además, las declaraciones con perspectivas de futuro también pueden verse afectadas de manera adversa por factores generales del mercado, desarrollo de productos de la competencia, disponibilidad de productos, normas y leyes federales y estatales, el proceso regulatorio de nuevos productos, entre otros factores. Las proyecciones que contiene este comunicado de prensa solo expresan la situación a la fecha en que se realizaron, y no asumimos obligación alguna de actualizar las proyecciones. Tenemos la intención de que todas las declaraciones con perspectivas de futuro estén sujetas a las disposiciones de puerto seguro de la ley PSLRA.

Powered by Translations.com GlobalLink OneLink Software